In contrast, miR-18a inhibitor significantly increased the expression of p21 in parallel with an enhanced KLF4 level, indicating that miR-18a may promote hepatocellular carcinoma cell growth and invasion by regulating the activity of KLF4 as well as downstream p21. Here, KLF4 is linked to hepatocellular carcinoma.